Reported results
- GAAP operating expenses were $214.6 million for the third quarter of 2026, compared to $234.2 million for the same period of the prior year.
- Non-GAAP operating expenses were $166.9 million for the third quarter of 2026, compared to $103.4 million for the same period of the prior year.
- GAAP R&D expenses were $169.1 million for the third quarter of 2026, compared to $131.1 million for the same period of the prior year.
- Non-GAAP R&D expenses were $145.2 million for the third quarter of 2026, compared to $90.5 million for the same period of the prior year.
- GAAP net loss in the third quarter of 2026 was $208.4 million, or $(0.26) per basic and diluted share.
- Non-GAAP net loss in the third quarter of 2026 was $160.7 million, or $(0.20) per basic and diluted share.
Notes
The company notes that GAAP financial measures are adjusted for stock-based compensation to arrive at non-GAAP financial measures.
Price and volatility reaction
The stock moved -12.2% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +23.0 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 16.17 | 2026-11-04 |
| Close after release | 14.19 | 2026-11-05 |
| Realised move | -12.2% | close to close |
| 30d ATM IV change | +23.0 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-04 (8-K, Item 2.02). Read the original filing on sec.gov.
